Warburg Research Analysts Give Drägerwerk AG & Co. KGaA (ETR:DRW3) a €52.70 Price Target

Warburg Research set a €52.70 ($56.67) target price on Drägerwerk AG & Co. KGaA (ETR:DRW3Get Rating) in a research note released on Friday, Borsen Zeitung reports.

Separately, Kepler Capital Markets set a €55.00 ($59.14) price objective on shares of Drägerwerk AG & Co. KGaA in a research note on Tuesday, January 11th.

Shares of ETR:DRW3 opened at €47.20 ($50.75) on Friday. The company has a market capitalization of $405.92 million and a price-to-earnings ratio of 6.47. Drägerwerk AG & Co. KGaA has a 52 week low of €46.45 ($49.95) and a 52 week high of €82.70 ($88.92). The company has a quick ratio of 1.41, a current ratio of 2.13 and a debt-to-equity ratio of 27.66. The firm has a 50 day moving average of €50.59 and a 200 day moving average of €55.65.

Drägerwerk AG & Co. KGaA Company Profile (Get Rating)

Drägerwerk AG & Co KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.

Featured Stories

Receive News & Ratings for Drägerwerk AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Drägerwerk AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.